rs4252117

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000301.5(PLG):​c.1097-64A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.246 in 1,210,450 control chromosomes in the GnomAD database, including 41,226 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.21 ( 4001 hom., cov: 32)
Exomes 𝑓: 0.25 ( 37225 hom. )

Consequence

PLG
NM_000301.5 intron

Scores

3

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0120

Publications

14 publications found
Variant links:
Genes affected
PLG (HGNC:9071): (plasminogen) The plasminogen protein encoded by this gene is a serine protease that circulates in blood plasma as an inactive zymogen and is converted to the active protease, plasmin, by several plasminogen activators such as tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman factor). The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Plasmin cleavage also releases the angiostatin protein which inhibits angiogenesis. Plasmin degrades many blood plasma proteins, including fibrin-containing blood clots. As a serine protease, plasmin cleaves many products in addition to fibrin such as fibronectin, thrombospondin, laminin, and von Willebrand factor. Plasmin is inactivated by proteins such as alpha-2-macroglobulin and alpha-2-antiplasmin in addition to inhibitors of the various plasminogen activators. Plasminogen also interacts with plasminogen receptors which results in the retention of plasmin on cell surfaces and in plasmin-induced cell signaling. The localization of plasminogen on cell surfaces plays a role in the degradation of extracellular matrices, cell migration, inflamation, wound healing, oncogenesis, metastasis, myogenesis, muscle regeneration, neurite outgrowth, and fibrinolysis. This protein may also play a role in acute respiratory distress syndrome (ARDS) which, in part, is caused by enhanced clot formation and the suppression of fibrinolysis. Compared to other mammals, the cluster of plasminogen-like genes to which this gene belongs has been rearranged in catarrhine primates. [provided by RefSeq, May 2020]
PLG Gene-Disease associations (from GenCC):
  • hypoplasminogenemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • angioedema, hereditary, 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000301.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 6-160722344-A-G is Benign according to our data. Variant chr6-160722344-A-G is described in ClinVar as Benign. ClinVar VariationId is 1258345.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000301.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLG
NM_000301.5
MANE Select
c.1097-64A>G
intron
N/ANP_000292.1P00747

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLG
ENST00000308192.14
TSL:1 MANE Select
c.1097-64A>G
intron
N/AENSP00000308938.9P00747
PLG
ENST00000872438.1
c.1097-64A>G
intron
N/AENSP00000542497.1
PLG
ENST00000872435.1
c.1097-64A>G
intron
N/AENSP00000542494.1

Frequencies

GnomAD3 genomes
AF:
0.211
AC:
32094
AN:
151968
Hom.:
4005
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.103
Gnomad AMI
AF:
0.224
Gnomad AMR
AF:
0.196
Gnomad ASJ
AF:
0.306
Gnomad EAS
AF:
0.00173
Gnomad SAS
AF:
0.102
Gnomad FIN
AF:
0.262
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.291
Gnomad OTH
AF:
0.228
GnomAD4 exome
AF:
0.251
AC:
265523
AN:
1058364
Hom.:
37225
AF XY:
0.248
AC XY:
135280
AN XY:
545312
show subpopulations
African (AFR)
AF:
0.0974
AC:
2505
AN:
25728
American (AMR)
AF:
0.128
AC:
5590
AN:
43828
Ashkenazi Jewish (ASJ)
AF:
0.291
AC:
6878
AN:
23658
East Asian (EAS)
AF:
0.000529
AC:
20
AN:
37794
South Asian (SAS)
AF:
0.107
AC:
8355
AN:
78152
European-Finnish (FIN)
AF:
0.262
AC:
13837
AN:
52820
Middle Eastern (MID)
AF:
0.255
AC:
1268
AN:
4964
European-Non Finnish (NFE)
AF:
0.290
AC:
215760
AN:
744402
Other (OTH)
AF:
0.241
AC:
11310
AN:
47018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
9491
18981
28472
37962
47453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5492
10984
16476
21968
27460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.211
AC:
32085
AN:
152086
Hom.:
4001
Cov.:
32
AF XY:
0.207
AC XY:
15372
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.103
AC:
4253
AN:
41480
American (AMR)
AF:
0.196
AC:
2996
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.306
AC:
1059
AN:
3466
East Asian (EAS)
AF:
0.00174
AC:
9
AN:
5180
South Asian (SAS)
AF:
0.103
AC:
495
AN:
4818
European-Finnish (FIN)
AF:
0.262
AC:
2769
AN:
10574
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.291
AC:
19760
AN:
67962
Other (OTH)
AF:
0.225
AC:
476
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1295
2590
3885
5180
6475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.260
Hom.:
8314
Bravo
AF:
0.204
Asia WGS
AF:
0.0460
AC:
162
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.5
DANN
Benign
0.56
PhyloP100
-0.012
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4252117;
hg19: chr6-161143376;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.